leadf
logo-loader
viewNEXTLEAF SOLUTIONS Ltd.

Nextleaf Solutions gets key Canadian patent and Health Canada approval for controlled human trials

Nextleaf Solutions (CSE: OILS- OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive with news the company has been issued its 70th worldwide patent. This one covers the process for acetylating cannabidiol and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Pedersen also shared with Proactive, Health Canada has granted the company a research licence to conduct controlled human administration trials for sensory evaluation of cannabis at its processing facility in Metro Vancouver.

Quick facts: NEXTLEAF SOLUTIONS Ltd.

Price: 0.28 CAD

CSE:OILS
Market: CSE
Market Cap: $33.74 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of NEXTLEAF SOLUTIONS Ltd. named herein, including the promotion by the Company of NEXTLEAF SOLUTIONS Ltd. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Nextleaf Solutions signs supply agreement with Bevcanna, a Cannabis infused...

Nextleaf Solutions (CSE: OILS- OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive to share details the company’s Rapid Emulsion Technology by OILS will be used to provide THC and CBD concentrate for BevCanna to use in both their brands and their partner brands. Pedersen...

4 days, 13 hours ago

2 min read